BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 34270542)

  • 21. Prognosis of polypoid melanoma: a comparative study with non-polypoid melanomas.
    Jasso-Sosa VY; Lino-Silva LS; Escobar-Jiménez MG; Galván-Bustillos JR; García-Ortega DY; Salcedo-Hernández RA; Zepeda-Najar C; Frías-Fernández P
    Melanoma Res; 2023 Jun; 33(3):257-261. PubMed ID: 36866632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prognostic significance of ulceration of cutaneous melanoma.
    Balch CM; Wilkerson JA; Murad TM; Soong SJ; Ingalls AL; Maddox WA
    Cancer; 1980 Jun; 45(12):3012-7. PubMed ID: 7388745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Value of anatomic site, histology and clinicopathological parameters for prediction of lymph node metastasis and overall survival in head and neck melanomas.
    Ettl T; Irga S; Müller S; Rohrmeier C; Reichert TE; Schreml S; Gosau M
    J Craniomaxillofac Surg; 2014 Jul; 42(5):e252-8. PubMed ID: 24216129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Survival analysis and sentinel lymph node status in thin cutaneous melanoma: A multicenter observational study.
    Tejera-Vaquerizo A; Ribero S; Puig S; Boada A; Paradela S; Moreno-Ramírez D; Cañueto J; de Unamuno B; Brinca A; Descalzo-Gallego MA; Osella-Abate S; Cassoni P; Carrera C; Vidal-Sicart S; Bennássar A; Rull R; Alos L; Requena C; Bolumar I; Traves V; Pla Á; Fernández-Orland A; Jaka A; Fernández-Figueres MT; Hilari JM; Giménez-Xavier P; Vieira R; Botella-Estrada R; Román-Curto C; Ferrándiz L; Iglesias-Pena N; Ferrándiz C; Malvehy J; Quaglino P; Nagore E;
    Cancer Med; 2019 Aug; 8(9):4235-4244. PubMed ID: 31215168
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of higher risk thin melanomas should be based on Breslow depth not Clark level IV.
    Owen SA; Sanders LL; Edwards LJ; Seigler HF; Tyler DS; Grichnik JM
    Cancer; 2001 Mar; 91(5):983-91. PubMed ID: 11251950
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.
    Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L
    Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sentinel lymph node biopsy in thick malignant melanoma: a 10-year single unit experience.
    Fairbairn NG; Orfaniotis G; Butterworth M
    J Plast Reconstr Aesthet Surg; 2012 Oct; 65(10):1396-402. PubMed ID: 22552263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A retrospective multicenter evaluation of cutaneous melanomas in Turkey.
    Gamsizkan M; Yilmaz I; Buyukbabani N; Demirkesen C; Demiriz M; Cetin ED; Ince U; Akalin T; Demirkan NC; Lebe B; Erdem O; Gokoz O; Sakiz D; Demireli PT; Astarci HM; Adim SB; Zemheri IE; Acikalin A; Yaman B; Aydin O; Bassorgun CI
    Asian Pac J Cancer Prev; 2014; 15(23):10451-6. PubMed ID: 25556491
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regression does not predict nodal metastasis or survival in patients with cutaneous melanoma.
    Burton AL; Gilbert J; Farmer RW; Stromberg AJ; Hagendoorn L; Ross MI; Martin RC; McMasters KM; Scoggins CR; Callender GG
    Am Surg; 2011 Aug; 77(8):1009-13. PubMed ID: 21944515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical impact of sentinel lymph node biopsy in patients with thick (>4 mm) melanomas.
    White I; Fortino J; Curti B; Vetto J
    Am J Surg; 2014 May; 207(5):702-7; discussion 707. PubMed ID: 24791630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Should all patients with melanoma between 1 and 2 mm Breslow thickness undergo sentinel lymph node biopsy?
    Mays MP; Martin RC; Burton A; Ginter B; Edwards MJ; Reintgen DS; Ross MI; Urist MM; Stromberg AJ; McMasters KM; Scoggins CR
    Cancer; 2010 Mar; 116(6):1535-44. PubMed ID: 20108306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mortality burden and prognosis of thin melanomas overall and by subcategory of thickness, SEER registry data, 1992-2013.
    Landow SM; Gjelsvik A; Weinstock MA
    J Am Acad Dermatol; 2017 Feb; 76(2):258-263. PubMed ID: 27887797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surgical resection margin for T3-T4 primary acral melanoma: a multicenter retrospective cohort study.
    Sun W; Xu Y; Qu X; Jin Y; Wang C; Yan W; Chen Y
    Arch Dermatol Res; 2023 Oct; 315(8):2305-2312. PubMed ID: 36988664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Depth of invasion analysis to predict acral melanoma outcomes.
    Asato MA; Moares-Neto FA; de Toledo Moraes MP; Ocanha-Xavier JP; Takita LC; Marques MEA; Xavier-Júnior JCC
    Ann Diagn Pathol; 2024 Aug; 71():152305. PubMed ID: 38640808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The current management and prognosis of acral lentiginous melanoma.
    Wells KE; Reintgen DS; Cruse CW
    Ann Plast Surg; 1992 Jan; 28(1):100-3. PubMed ID: 1642394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic Significance of Periadnexal Extension in Cutaneous Melanoma and its Implications for Pathologic Reporting and Staging.
    Dodds TJ; Lo S; Jackett L; Nieweg O; Thompson JF; Scolyer RA
    Am J Surg Pathol; 2018 Mar; 42(3):359-366. PubMed ID: 29240580
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sentinel node biopsy should be offered in thin melanoma with mitotic rate greater than one.
    Sekula-Gibbs SA; Shearer MA
    Dermatol Surg; 2011 Aug; 37(8):1080-8. PubMed ID: 21635622
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Excision margins and sentinel lymph node status as prognostic factors in thick melanoma of the head and neck: A retrospective analysis.
    Ruskin O; Sanelli A; Herschtal A; Webb A; Dixon B; Pohl M; Donahoe S; Spillane J; Henderson MA; Gyorki DE
    Head Neck; 2016 Sep; 38(9):1373-9. PubMed ID: 27014970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and pathologic factors associated with distant metastasis and survival in patients with thin primary cutaneous melanoma.
    Murali R; Haydu LE; Long GV; Quinn MJ; Saw RP; Shannon K; Spillane AJ; Stretch JR; Kefford RF; Thompson JF; Scolyer RA
    Ann Surg Oncol; 2012 Jun; 19(6):1782-9. PubMed ID: 22350600
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Melanoma in Mexico: Clinicopathologic Features in a Population with Predominance of Acral Lentiginous Subtype.
    Lino-Silva LS; Domínguez-Rodríguez JA; Aguilar-Romero JM; Martínez-Said H; Salcedo-Hernández RA; García-Pérez L; Herrera-Gómez Á; Cuellar-Hubbe M
    Ann Surg Oncol; 2016 Dec; 23(13):4189-4194. PubMed ID: 27401447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.